COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,221 Articles (22,733 medRxiv, 8,488 bioRxiv)

Most recent first Previous |  Page 12: Articles 111-120  | Next

Whole genome sequence meta-analyses reveal common and rare genetic associations with critical COVID-19
Kousathanas, A., Rawlik, K., Pairo-Castineira, E., Griffiths, F., Oosthuyzen, W., Clohisey Hendry, S., Malinauskas, T., Butler-Laporte, G., Arumugam, P., Begg, C., Chadeau-Hyam, M., Chan, G., Cooke, G., Donovan, S., Elgar, G., Fowler, T. A., Goddard, P., Hinds, C., Horby, P., Ling, L., Magavern, E. F., Maleady-Crowe, F., Montgomery, H., Odhams, C. A., Openshaw, P. J. M., Patch, C., Rendon, A., Salehi, S., Scott, R. H., Semple, M. G., Shankar-Hari, M., Siddiq, A., Stuckey, A., Summers, C., Todd, L., Walker, S., Walsh, T., Ward, H., Zainy, T., GenOMICC Investigators, , ISARIC4C Investigators
10.1101/2025.11.19.25340573 — Posted: 2025-11-21
Increased mannosylation of extracellular vesicles in Long COVID plasma provides a potential therapeutic target for Galanthus nivalis agglutinin (GNA) affinity resin
Pesqueira Sanchez, M. A., de Necochea Campion, R., Dalhuisen, T., Fehrman, E. A., Chhabra, P. S., Kelly, J. D., Martin, J. N., Deeks, S. G., Henrich, T. J., Peluso, M. J., LaRosa, S. P.
10.1101/2025.11.21.689519 — Posted: 2025-11-21
Antigen-reactive CD4+ T cells after SARS-CoV-2 vaccination show divergent phenotypic states with or without restimulation bias
Kocher, K., Drost, F., Schuelein, C., Spriewald, B., Schubert, B., Schober, K.
10.1101/2025.11.19.688845 — Posted: 2025-11-21
Prediction of Long COVID and Mortality among Patients with Substance Use Disorder
Wu, J., Islam, K. M. S., Madiraju, P.
10.1101/2025.11.19.25340587 — Posted: 2025-11-20
A highly divergent cryptic SARS-CoV-2 lineage exhibits strong receptor binding and immune evasion
Feng, Z., Teo, Q. W., Ibrahim, B. A., Liu, W., Zhang, D., Mao, K. J., Shao, E. K., Gregory, D. A., Wilson, I. A., Johnson, M. C., Yuan, M., Wu, N. C.
10.1101/2025.11.18.25340485 — Posted: 2025-11-20
Omicron evolution drives increased ciliated cell tropism and dysfunction in nasal epithelia.
Parry, R., Mostafavi, H., McCallum, G., Sng, J. D. J., Joensuu, M., Short, K. R., Slonchak, A., Khromykh, A.
10.1101/2025.11.19.689397 — Posted: 2025-11-20
Pathogenic IgG from long COVID patients with neurological sequelae triggers sensitive but not cognitive impairments upon transfer into mice
Mignolet, M., Deroux, C., Florkin, T., Bielarz, V., De Swert, K., Halloin, N., Sprimont, L., Ladang, A., George, F., Gilloteaux, J., Abeloos, L., Van Weyenbergh, J., Jamoulle, M., Diederich, C., Gillet, N. A., Bulpa, P., Nicaise, C.
10.1101/2025.11.20.689423 — Posted: 2025-11-20
Humoral immunity induced by LP.8.1 monovalent vaccines against a broad range of SARS-CoV-2 variants including XEC, NB.1.8.1, XFG, and BA.3.2
Kaku, Y., Fujiwara, M., Uriu, K., Yo, M. S., Kawakubo, S., Ito, J., Itoh, N., Uwamino, Y., Saito, F., Satoh, H., The Genotype to Phenotype Japan (G2P-Japan) Consortium, , Sato, K.
10.1101/2025.11.18.689152 — Posted: 2025-11-20
A SARS-CoV-2 entry inhibitor trimerizes to lock the spike protein in a closed conformation
Mou, H., Gao, B., Ye, G., Zhang, L., Saxena, D., Bu, F., Vishwakarma, J., Zhou, S., Bayona, C. R., Li, L., Getmanenko, Y., Bhandari, J., Bailey, C. C., Crynen, G. C., Kitzmiller, C. E., Li, H., Otsuka, Y., Wang, C., Batra, L., Weston, S., Frieman, M. B., Meyerholz, D. K., Scampavia, L., Spicer, T., Harris, R. S., Cameron, M., Bannister, T., Zheng, J., Farzan, M., Li, F., Choe, H.
10.1101/2025.11.19.689107 — Posted: 2025-11-20
Risk-Based Prioritization for COVID-19 Vaccination in the Post-Emergency Phase
Yechezkel, M., Faust, J., Netzer, D., Razi-Benita, T., Shmueli, E., Arbel, R., Yamin, D.
10.1101/2025.11.18.25340522 — Posted: 2025-11-19

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).